Urotensin II and urotensin II-related peptide activate somatostatin receptor subtypes 2 and 5

Peptides

Volumn 29, Issue 5, 2008, Pages 711-720

  Malagon, Maria M ^a,b   Molina, Marcelo ^a   Gahete, Manuel D ^a,b   Duran Prado, Mario ^a   Martinez Fuentes, Antonio J ^a,b   Alcain, Francisco J ^a   Tonon, Marie Christine ^c   Leprince, Jérôme ^c   Vaudry, Hubert ^c   Castaño, Justo P ^a,b   Vazquez Martinez, Rafael ^a,b  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITÉ DE ROUEN   (France)

Author keywords

Intracellular Ca2+; Proliferation; Somatostatin; Somatostatin receptors; Urotensin II; Urotensin II related peptide

Indexed keywords

CALCIUM ION; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 5; UNCLASSIFIED DRUG; UROTENSIN II; UROTENSIN II RELATED PEPTIDE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CALCIUM; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; PEPTIDE HORMONES; QUINOLINES; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; SWINE; UREA; UROTENSINS;

SUS;

EID: 42049112265     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.12.015     Document Type: Article

References (49)

1. Albertin G., Casale V., Ziolkowska A., Spinazzi R., Malendowicz L.K., Rossi G.P., et al. Urotensin-II and UII-receptor expression and function in the rat adrenal cortex. Int J Mol Med 17 (2006) 1111-1115
2. Alderton F., Fan T.P., Schindler M., and Humphrey P.P. Rat somatostatin sst2(a) and sst2(b) receptor isoforms mediate opposite effects on cell proliferation. Br J Pharmacol 125 (1998) 1630-1633
3. Alderton F., Lauder H., Feniuk W., Fan T.P., and Humphrey P.P. Differential effects of somatostatin and angiopeptin on cell proliferation. Br J Pharmacol 124 (1998) 323-330
4. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 (1999) 282-286
5. Ashton N. Renal and vascular actions of urotensin II. Kidney Int 70 (2006) 624-629
6. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179 (1973) 77-79
7. Buscail L., Esteve J.P., Saint-Laurent N., Bertrand V., Reisine T., O'Carroll A.M., et al. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci USA 92 (1995) 1580-1584
8. Castel H., Diallo M., Chatenet D., Leprince J., Desrues L., Schouft M.T., et al. Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes. J Neurochem 99 (2006) 582-595
9. Clozel M., Binkert C., Birker-Robaczewska M., Boukhadra C., Ding S.S., Fischli W., et al. Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-y l)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin system. J Pharmacol Exp Ther 311 (2004) 204-212
10. Conlon J.M., Yano K., Waugh D., and Hazon N. Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates. J Exp Zool 275 (1996) 226-238
11. Coy D.H., Rossowski W.J., Cheng B.L., and Taylor J.E. Structural requirements at the N-terminus of urotensin II octapeptides. Peptides 23 (2002) 2259-2264
12. Chatenet D., Dubessy C., Boularan C., Scalbert E., Pfeiffer B., Renard P., et al. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist. J Med Chem 49 (2006) 7234-7238
13. Chatenet D., Dubessy C., Leprince J., Boularan C., Carlier L., Segalas-Milazzo I., et al. Structure-activity relationships and structural conformation of a novel urotensin II-related peptide. Peptides 25 (2004) 1819-1830
14. de Lecea L., Criado J.R., Prospero-Garcia O., Gautvik K.M., Schweitzer P., Danielson P.E., et al. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381 (1996) 242-245
15. Douglas S.A., and Ohlstein E.H. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med 10 (2000) 229-237
16. Duran-Prado M., Bucharles C., Gonzalez B.J., Vazquez-Martinez R., Martinez-Fuentes A.J., Garcia-Navarro S., et al. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization. Endocrinology 148 (2007) 411-421
17. Ferjoux G., Bousquet C., Cordelier P., Benali N., Lopez F., Rochaix P., et al. Signal transduction of somatostatin receptors negatively controlling cell proliferation. J Physiol Paris 94 (2000) 205-210
18. Flohr S., Kurz M., Kostenis E., Brkovich A., Fournier A., and Klabunde T. Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. J Med Chem 45 (2002) 1799-1805
19. Hill S.J. G-protein-coupled receptors: past, present and future. Br J Pharmacol 147 (2006) S27-S37
20. Huitron-Resendiz S., Kristensen M.P., Sanchez-Alavez M., Clark S.D., Grupke S.L., Tyler C., et al. Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci 25 (2005) 5465-5474
21. Hunyady B., Hipkin R.W., Schonbrunn A., and Mezey E. Immunohistochemical localization of somatostatin receptor SST2A in the rat pancreas. Endocrinology 138 (1997) 2632-2635
22. Jegou S., Cartier D., Dubessy C., Gonzalez B.J., Chatenet D., Tostivint H., et al. Localization of the urotensin II receptor in the rat central nervous system. J Comp Neurol 495 (2006) 21-36
23. Labarrere P., Chatenet D., Leprince J., Marionneau C., Loirand G., Tonon M.C., et al. Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction. J Enzyme Inhib Med Chem 18 (2003) 77-88
24. Lehmann F., Pettersen A., Currier E.A., Sherbukhin V., Olsson R., Hacksell U., et al. Novel potent and efficacious nonpeptidic urotensin II receptor agonists. J Med Chem 49 (2006) 2232-2240
25. Leprince J., Chatenet D., Dubessy C., Fournier A., Pfeiffer B., Scalbert E., et al. Structure-activity relationships of urotensin II and URP. Peptides 29 (2008) 658-673
26. Lescot E., Sopkova-de Oliveira Santos J., Dubessy C., Oulyadi H., Lesnard A., Vaudry H., et al. Definition of new pharmacophores for nonpeptide antagonists of human urotensin-II. Comparison with the 3D-structure of human urotensin-II and URP. J Chem Inf Model 47 (2007) 602-612
27. Liu Q., Cescato R., Dewi D.A., Rivier J., Reubi J.C., and Schonbrunn A. Receptor signaling and endocytosis are differentially regulated by somatostatin analogs. Mol Pharmacol 68 (2005) 90-101
28. Liu Q., Pong S.S., Zeng Z., Zhang Q., Howard A.D., Williams Jr. D.L., et al. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 266 (1999) 174-178
29. Lopez F., Esteve J.P., Buscail L., Delesque N., Saint-Laurent N., Vaysse N., et al. Molecular mechanisms of antiproliferative effect of somatostatin: involvement of a tyrosine phosphatase. Metabolism 45 (1996) 14-16
30. Luque R.M., Duran-Prado M., Garcia-Navarro S., Gracia-Navarro F., Kineman R.D., Malagon M.M., et al. Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion. Endocrinology 147 (2006) 2902-2908
31. Marchese A., Heiber M., Nguyen T., Heng H.H., Saldivia V.R., Cheng R., et al. Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics 29 (1995) 335-344
32. Marco J, Egido EM, Hernandez R, Silvestre RA. Evidence for endogenous urotensin-II as an inhibitor of insulin secretion study in the perfused rat pancreas. Peptides; this issue.
33. Matsushita M., Shichiri M., Imai T., Iwashina M., Tanaka H., Takasu N., et al. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19 (2001) 2185-2190
34. Mitra S.W., Mezey E., Hunyady B., Chamberlain L., Hayes E., Foor F., et al. Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta-cells. Endocrinology 140 (1999) 3790-3796
35. Mori M., and Fujino M. Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain. Peptides 25 (2004) 1815-1818
36. Mori M., Sugo T., Abe M., Shimomura Y., Kurihara M., Kitada C., et al. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem Biophys Res Commun 265 (1999) 123-129
37. Nothacker H.P., Wang Z., McNeill A.M., Saito Y., Merten S., O'Dowd B., et al. Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1 (1999) 383-385
38. Olias G., Viollet C., Kusserow H., Epelbaum J., and Meyerhof W. Regulation and function of somatostatin receptors. J Neurochem 89 (2004) 1057-1091
39. Ong KL, Wong LY, Cheung BM. The role of urotensin II in the metabolic syndrome. Peptides; this issue.
40. Patacchini R., Santicioli P., Giuliani S., Grieco P., Novellino E., Rovero P., et al. Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta. Br J Pharmacol 140 (2003) 1155-1158
41. Pearson D., Shively J.E., Clark B.R., Geschwind I.I., Barkley M., Nishioka R.S., et al. Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci USA 77 (1980) 5021-5024
42. Prosser HC, Forster ME, Richards AM, Pemberton CJ. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury. Peptides; this issue.
43. Rohrer S.P., Birzin E.T., Mosley R.T., Berk S.C., Hutchins S.M., Shen D.M., et al. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282 (1998) 737-740
44. Rohrer S.P., and Schaeffer J.M. Identification and characterization of subtype selective somatostatin receptor agonists. J Physiol Paris 94 (2000) 211-215
45. Rossowski W.J., Cheng B.L., Taylor J.E., Datta R., and Coy D.H. Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. Eur J Pharmacol 438 (2002) 159-170
46. Silvestre R.A., Egido E.M., Hernandez R., Leprince J., Chatenet D., Tollemer H., et al. Urotensin-II is present in pancreatic extracts and inhibits insulin release in the perfused rat pancreas. Eur J Endocrinol 151 (2004) 803-809
47. Sugo T., Murakami Y., Shimomura Y., Harada M., Abe M., Ishibashi Y., et al. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem Biophys Res Commun 310 (2003) 860-868
48. Tostivint H., Joly L., Lihrmann I., Parmentier C., Lebon A., Morisson M., et al. Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families. Proc Natl Acad Sci USA 103 (2006) 2237-2242
49. Tostivint H., Lihrmann I., and Vaudry H. Urotensin II and somatostatin: two old cousins get together again. Med Sci (Paris) 22 (2006) 476-478